Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.
2.

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Age-Related Eye Disease Study Research Group.

Arch Ophthalmol. 2001 Oct;119(10):1417-36. Erratum in: Arch Ophthalmol. 2008 Sep;126(9):1251.

3.

Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.

Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Kurinij N, Davis MD; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2013 Aug;120(8):1604-11.e4. doi: 10.1016/j.ophtha.2013.01.021. Epub 2013 Apr 10.

4.

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.

Age-Related Eye Disease Study Research Group.

Arch Ophthalmol. 2001 Oct;119(10):1439-52. Erratum in: Arch Ophthalmol. 2008 Sep;126(9):1251.

5.

CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.

Awh CC, Lane AM, Hawken S, Zanke B, Kim IK.

Ophthalmology. 2013 Nov;120(11):2317-23. doi: 10.1016/j.ophtha.2013.07.039. Epub 2013 Aug 21.

PMID:
23972322
6.

Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Age-Related Eye Disease Study 2 Research Group.

JAMA. 2013 May 15;309(19):2005-15. doi: 10.1001/jama.2013.4997. Erratum in: JAMA. 2013 Jul 10;310(2):208.

PMID:
23644932
7.

Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.

Bressler NM, Bressler SB, Congdon NG, Ferris FL 3rd, Friedman DS, Klein R, Lindblad AS, Milton RC, Seddon JM; Age-Related Eye Disease Study Research Group.

Arch Ophthalmol. 2003 Nov;121(11):1621-4.

8.

Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.

Tan JS, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P.

Ophthalmology. 2008 Feb;115(2):334-41. Epub 2007 Jul 30.

PMID:
17664009
9.

Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32.

Chang JR, Koo E, Agrón E, Hallak J, Clemons T, Azar D, Sperduto RD, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study Group.

Ophthalmology. 2011 Nov;118(11):2113-9. doi: 10.1016/j.ophtha.2011.03.032.

10.

Current use of dietary supplementation in patients with age-related macular degeneration.

Chang CW, Chu G, Hinz BJ, Greve MD.

Can J Ophthalmol. 2003 Feb;38(1):27-32.

PMID:
12608514
11.

Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25.

Chew EY, Sperduto RD, Milton RC, Clemons TE, Gensler GR, Bressler SB, Klein R, Klein BE, Ferris FL 3rd.

Ophthalmology. 2009 Feb;116(2):297-303. doi: 10.1016/j.ophtha.2008.09.019. Epub 2008 Dec 16.

12.

Changes in lens opacities on the age-related eye disease study grading scale predict progression to cataract surgery and vision loss: age-related eye disease study report no. 34.

Indaram M, Agrón E, Clemons TE, Sperduto RD, Wong WT, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2015 May;122(5):888-96. doi: 10.1016/j.ophtha.2014.12.037. Epub 2015 Feb 11.

13.

Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.

Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2005 Apr;112(4):533-9.

14.

The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).

AREDS2 Research Group, Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W, Sperduto R, Ferris FL.

Ophthalmology. 2012 Nov;119(11):2282-9. doi: 10.1016/j.ophtha.2012.05.027. Epub 2012 Jul 26.

15.

[Vitamins and trace elements in age-related macular degeneration. Current recommendations, based on the results of the AREDS study].

Schütt F, Pauleikhoff D, Holz FG.

Ophthalmologe. 2002 Apr;99(4):301-3. German. No abstract available.

PMID:
12058509
16.

Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.

Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Davis MD, Ferris FL 3rd; Age-Related Eye Disease Study Research Group.

JAMA Ophthalmol. 2014 Mar;132(3):272-7. doi: 10.1001/jamaophthalmol.2013.6636.

PMID:
24385141
17.

Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study.

Awh CC, Hawken S, Zanke BW.

Ophthalmology. 2015 Jan;122(1):162-9. doi: 10.1016/j.ophtha.2014.07.049. Epub 2014 Sep 4.

PMID:
25200399
18.

The short-term effects of antioxidant and zinc supplements on oxidative stress biomarker levels in plasma: a pilot investigation.

Brantley MA Jr, Osborn MP, Sanders BJ, Rezaei KA, Lu P, Li C, Milne GL, Cai J, Sternberg P Jr.

Am J Ophthalmol. 2012 Jun;153(6):1104-9.e2. doi: 10.1016/j.ajo.2011.12.010. Epub 2012 Mar 3.

19.

The age-related eye disease study: the results of the clinical trial.

Sackett CS, Schenning S.

Insight. 2002 Jan-Mar;27(1):5-7.

PMID:
11962062
20.

No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.

Chew EY, Klein ML, Clemons TE, Agrón E, Ratnapriya R, Edwards AO, Fritsche LG, Swaroop A, Abecasis GR; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2014 Nov;121(11):2173-80. doi: 10.1016/j.ophtha.2014.05.008. Epub 2014 Jun 26.

Supplemental Content

Support Center